Posachedwa, Novo Nordisk adatulutsa lipoti lake lazachuma la 2022. Deta ikuwonetsa kuti malonda onse a Novo Nordisk mu 2022 adzafika ku 176.954 biliyoni Danish krone (US $ 24.994 biliyoni, kutembenuka kwamtengo wapatali komwe kunalengezedwa mu lipoti la pachaka, momwemonso pansipa), mpaka 26% chaka ndi chaka, phindu logwiritsira ntchito lidzafika 74.809 biliyoni Danish krone. (US $ 10.566 biliyoni), kukwera 28% chaka ndi chaka, ndipo phindu lonse lidzakhala 55.525 biliyoni Danish krone (US $ 7.843 biliyoni), mpaka 16% chaka ndi chaka. Kachitidweko ndi kochititsa chidwi kwambiri.

Kodi ntchito zabwino za Novo Nordisk zimachokera kuti? Yankho lake ndi GLP-1 analogue. M'mapaipi azinthu a Novo Nordisk, zinthu zitha kugawidwa m'mitundu inayi: ma analogue a GLP-1, insulin ndi ma analogues, zinthu zophatikizika ndi mahomoni ena a metabolic, ndikugulitsa 83.371 biliyoni Danish krone ($ 11.176 biliyoni, kupatula singano zowonda), 52.952 biliyoni Danish Danish. krone ($ 7.479 biliyoni), 11.706 biliyoni Danish krone ($1.653 biliyoni) ndi 7.138 biliyoni Danish krone ($1.008 biliyoni), motsatana. Mwa ma analogue a GLP-1, kugulitsa kwa jakisoni wa Liraglutide hypoglycemic kwakhala kutsika chaka ndi chaka, pomwe.Semaglutidendiwopatsa chidwi kwambiri, ndikugulitsa ndalama zokwana 10.882 biliyoni mu 2022.